U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H45NO3
Molecular Weight 371.5976
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of STEARIC DIETHANOLAMIDE

SMILES

CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCO

InChI

InChIKey=XGZOMURMPLSSKQ-UHFFFAOYSA-N
InChI=1S/C22H45NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(26)23(18-20-24)19-21-25/h24-25H,2-21H2,1H3

HIDE SMILES / InChI
Stearic diethanolamide is derivative of stearic acid. It was used in the textile-processing industry as a fabric softener and plasticizer for sizings. Stearic diethanolamine is contained in coconut oil diethanolamine condensate, which is widely used in cosmetic formulations of bath oil, shampoo, conditioner, lipstick and hair dye.

Approval Year

Name Type Language
STEARAMIDE DEA
INCI  
INCI  
Preferred Name English
STEARIC DIETHANOLAMIDE
II  
Common Name English
STEARIC DIETHANOLAMIDE [II]
Common Name English
N,N-BIS(2-HYDROXYETHYL)STEARAMIDE
Systematic Name English
STEAROYL DIETHANOLAMIDE
Common Name English
N,N-BIS(2-HYDROXYETHYL)OCTADECANAMIDE
Systematic Name English
DIETHANOLAMINE STEARIC ACID AMIDE
Systematic Name English
Code System Code Type Description
FDA UNII
4V4H07OJB9
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY
CAS
93-82-3
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY
EPA CompTox
DTXSID4059091
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY
PUBCHEM
7163
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-280-1
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY
RXCUI
1314285
Created by admin on Mon Mar 31 17:52:36 GMT 2025 , Edited by admin on Mon Mar 31 17:52:36 GMT 2025
PRIMARY RxNorm